# AVJ-301 Clinical Trial: A Clinical Evaluation of AVJ-301 (Absorb™ BVS) in Japanese Population

Study · id `cardio:ct-nct01844284` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01844284](<https://clinicaltrials.gov/study/NCT01844284>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01844284

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 400 participants.

## Technical summary

Registry record NCT01844284. Randomized; single masking; primary purpose treatment. Start 2013-04 (actual); primary completion 2015-01 (actual). Results posted on 2019-02-06.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 400 participants (enrolled count; ClinicalTrials.gov record NCT01844284, source copy `cardio:ctgov-nct01844284-2020-10-08`, retrieved 2026-10-26)
- Started: 2013-04 (actual) (ClinicalTrials.gov record NCT01844284, source copy `cardio:ctgov-nct01844284-2020-10-08`, retrieved 2026-10-26)
- Primary completion: 2015-01 (actual) (ClinicalTrials.gov record NCT01844284, source copy `cardio:ctgov-nct01844284-2020-10-08`, retrieved 2026-10-26)
- Completion: 2019-01-16 (actual) (ClinicalTrials.gov record NCT01844284, source copy `cardio:ctgov-nct01844284-2020-10-08`, retrieved 2026-10-26)
- Results first posted: 2019-02-06 (ClinicalTrials.gov record NCT01844284, source copy `cardio:ctgov-nct01844284-2020-10-08`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT01844284, source copy `cardio:ctgov-nct01844284-2020-10-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01844284-2020-10-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: AVJ-301 Clinical Trial: A Clinical Evaluation of AVJ-301 (Absorb™ BVS) in Japanese Population
- Acronym: ABSORB JAPAN
- Condition: Coronary Artery Disease
- Condition: Myocardial Ischemia
- Intervention (Device): XIENCE PRIME®/XIENCE Xpedition™
- Intervention (Device): Absorb™ BVS
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan (`cardio:pubmed-26330419`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Bioresorbable Scaffold for Treatment of Coronary Artery Lesions: Intravascular Ultrasound Results From the ABSORB Japan Trial (`cardio:pubmed-29622143`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 Years (`cardio:pubmed-31918929`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Long-Term Outcomes of Absorb Bioresorbable Vascular Scaffold vs. Everolimus-Eluting Metallic Stent - A Randomized Comparison Through 5 Years in Japan (`cardio:pubmed-32213737`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: b14fe6f26da323ce53ced604452efe814b1e36091be8b8efad4be1871b3cfd67
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
